Autonomix Medical (NASDAQ:AMIX) Issues Quarterly Earnings Results

Autonomix Medical (NASDAQ:AMIX) announced its quarterly earnings results on Wednesday. The company reported $0.09 earnings per share for the quarter, FiscalAI reports.

Autonomix Medical Trading Down 0.1%

AMIX traded down $0.00 during midday trading on Wednesday, hitting $0.42. 343,463 shares of the company were exchanged, compared to its average volume of 1,029,699. The company’s 50 day simple moving average is $0.38 and its 200 day simple moving average is $0.52. The firm has a market capitalization of $2.88 million, a price-to-earnings ratio of -0.12 and a beta of -1.82. Autonomix Medical has a 1-year low of $0.20 and a 1-year high of $2.64.

Wall Street Analyst Weigh In

AMIX has been the topic of several analyst reports. Weiss Ratings raised Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research report on Monday, May 18th. Maxim Group cut their price target on Autonomix Medical from $5.00 to $2.00 and set a “buy” rating on the stock in a research report on Tuesday, February 17th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $2.00.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.